SYMBIO PHARMACEUTICALS
SymBio Pharmaceuticals Limited operates as a biopharmaceutical company. It offers Symbenda medicine for treating low-grade non-Hodgkin's lymphoma and chronic lymphatic leukemia in Singapore. The company was founded in 2005 and is headquartered in Tokyo, Japan.
SYMBIO PHARMACEUTICALS
Social Links:
Industry:
Biotechnology Health Care Pharmaceutical Therapeutics
Founded:
2005-03-01
Address:
Tokyo, Tokyo, Japan
Country:
Japan
Website Url:
http://www.symbiopharma.com
Total Employee:
51+
Status:
Active
Contact:
+81354721125
Total Funding:
745.85 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Tag Manager Google Font API Google Analytics Global Site Tag Font Awesome DNSSEC
Similar Organizations
Adamas Pharmaceuticals
Adamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Innovus Pharmaceuticals
Innovus Pharmaceuticals develops healthcare products for dermatology, autoimmune, respiratory, and sexual dysfunction diseases.
Eden Biologics
Eden Biologics is a biopharmaceutical company that develops biosimilars and accelerates the development programs for clients & partners.
Posvax
Posvax develops prophylactic vaccines for life cycle-related diseases affecting the elderly.
Scout Bio
Scout Bi is a biotechnology company that provides veterinary, animal health, and gene therapy.
Tivorsan Pharmaceuticals
Tivorsan Pharmaceuticals is a protein therapeutics company that focuses on treating neuromuscular disorders.
Tmunity Therapeutics
Tmunity Therapeutics is developing novel products to unleash the immunological potential of T cells
Current Employees Featured
Founder
Stock Details
Investors List
Whiz Partners
Whiz Partners investment in Post-IPO Debt - SymBio Pharmaceuticals
Whiz Partners
Whiz Partners investment in Post-IPO Equity - SymBio Pharmaceuticals
Yuki Maekawa
Yuki Maekawa investment in Series E - SymBio Pharmaceuticals
JAFCO
JAFCO investment in Series E - SymBio Pharmaceuticals
Osamu Ogawa
Osamu Ogawa investment in Series E - SymBio Pharmaceuticals
Cephalon
Cephalon investment in Series E - SymBio Pharmaceuticals
Waseda University
Waseda University investment in Venture Round - SymBio Pharmaceuticals
Whiz Partners
Whiz Partners investment in Venture Round - SymBio Pharmaceuticals
Waseda University
Waseda University investment in Corporate Round - SymBio Pharmaceuticals
Yasuda Enterprise Development
Yasuda Enterprise Development investment in Corporate Round - SymBio Pharmaceuticals
Official Site Inspections
http://www.symbiopharma.com Semrush global rank: 8.9 M Semrush visits lastest month: 562
- Host name: fb2153.secure.jp
- IP address: 150.60.144.180
- Location: Japan
- Latitude: 35.69
- Longitude: 139.69
- Timezone: Asia/Tokyo
More informations about "SymBio Pharmaceuticals"
Organization Chart - About SymBio - SymBio Pharmaceuticals …
Mar 1, 2025 Organization chart Diverse ties with individuals and companies will strengthen our business foundation and expand our activities. In addition to the Scientific Advisory Board and …See details»
Corporate Governance - About SymBio - SymBio
Mar 22, 2024 We have established an internal audit office as an independent organization reporting directly to the president, and have also appointed internal auditors to subsidiaries as necessary. By conducting regular audits, we …See details»
SymBio Pharmaceuticals
Although Nikkei BP grants permission to use the articles, the content of the articles does not constitute a recommendation to purchase/invest in a specific company/organization or …See details»
Org Chart SymBio Pharmaceuticals - The Official Board
The organizational chart of SymBio Pharmaceuticals displays its 14 main executives including Fuminori Yoshida, Takaaki Fukushima, Jay Feingold and Koji Fu...See details»
Company Profile - About SymBio - SymBio Pharmaceuticals …
Mar 25, 2005 name: SymBio Pharmaceuticals Limited: English name: SymBio Pharmaceuticals Limited: location: Toranomon Towers Office, 7th floor, 4-1-28 Toranomon, Minato-ku, Tokyo …See details»
SymBio Pharmaceuticals - Crunchbase Company Profile …
Treakisym: A therapeutic drug used in the treatment of cancer, available since 2011. Brincidofovir: An antiviral and antitumor drug under development for …See details»
Overview, News & Similar companies - ZoomInfo.com
Sep 23, 2020 Who is SymBio Pharmaceuticals. SymBio Pharmaceuticals Limited was established in March 2005 by Fuminori Yoshida, who previously served as both Corporate …See details»
SymBio Pharma USA, Inc. | The Org
SymBio Pharma USA Inc. is the US subsidiary of SymBio Pharmaceuticals Limited, a pharmaceutical company with headquarters in Tokyo, Japan. The mission of SymBio …See details»
SymBio Pharmaceuticals Ltd. - Drug pipelines, Patents, Clinical …
Explore SymBio Pharmaceuticals Ltd. with its drug pipeline, therapeutic area, technology platform, 25 clinical trials, 3 news, and 9 literature, Disease Domain:Hemic and Lymphatic Diseases, …See details»
SymBio Pharmaceuticals Company Profile | Management and
Www.symbiopharma.com SymBio Pharmaceuticals Profile and History SymBio Pharmaceuticals Limited was established in March 2005 by Fuminori Yoshida, who previously served as both …See details»
SymBio Pharmaceuticals Limited (4582.T) - Yahoo Finance
See the company profile for SymBio Pharmaceuticals Limited (4582.T) including business summary, industry/sector information, number of employees, business summary, corporate …See details»
Symbio - ARCHIMED
Symbio, based in NY, is a global full-service Clinical Research Organization (CRO) with offices in the US and Europe. In November 2023, Symbio merged with CA-based Dow Development …See details»
SymBio Pharmaceuticals - Products, Competitors, Financials, …
Symbiopharma.com. Overview & Products; Financials; Founded Year 2005. Stage IPO | IPO. Total Raised $24.5M. Date of IPO 10/20/2011. About SymBio Pharmaceuticals. SymBio …See details»
SymBio Pharmaceuticals Company Description - Stock Analysis
Feb 26, 2025 SymBio Pharmaceuticals Limited engages in the research and development, manufacturing, and sales of pharmaceuticals and related operations to treat cancer, …See details»
SymBio Pharmaceuticals Ltd Company Profile - Overview
Website www.symbiopharma.com Telephone 81 3 54721125. No of Employees 109. Industry Pharmaceuticals and Healthcare. Ticker Symbol & Exchange 4582 (TYO) Revenue (2023) …See details»
SYMBIO PHARMACEUTICALS LIMITED - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for SYMBIO PHARMACEUTICALS LIMITED of MINATO-KU, TOKYO. Get the latest business insights from …See details»
SymBio announces commencement of operations of SymBio
Phase of expansion and increased global capabilities for the Company. SymBio is a patient-centric organization committed to bringing novel therapeutics to the market for underserved …See details»
SymBio Pharmaceuticals Ltd, 4582:TYO profile - FT.com
3 days ago SymBio Pharmaceuticals Limited is a Japan-based pharmaceutical company. Along with medicine specialists, contract research organizations (CROs) and other pharmaceutical …See details»
SymBio Pharmaceuticals Ltd. (SymBio Pharmaceuticals Ltd.) - 药物 …
了解SymBio Pharmaceuticals Ltd. (SymBio Pharmaceuticals Ltd.)公司的药物管线，治疗领域，技术平台，以及它的25项临床试验, 2篇新闻和5篇文献，疾病领域:血液及淋巴系统疾病，肿瘤， …See details»
SymBio Pharmaceuticals Limited SymBio Pharmaceuticals - SymBio ...
We provide product information on prescription drugs provided by SymBio Pharmaceuticals for medical professionals in Japan.See details»